Page last updated: 2024-09-03

ru 24926 and u-50488

ru 24926 has been researched along with u-50488 in 1 studies

Compound Research Comparison

Studies
(ru 24926)
Trials
(ru 24926)
Recent Studies (post-2010)
(ru 24926)
Studies
(u-50488)
Trials
(u-50488)
Recent Studies (post-2010) (u-50488)
30001,6643209

Protein Interaction Comparison

ProteinTaxonomyru 24926 (IC50)u-50488 (IC50)
Delta-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorMus musculus (house mouse)0.0027
Mu-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.7171
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.0958
Kappa-type opioid receptorHomo sapiens (human)0.0537

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Degryse, M; Fortin, M; Hunt, PF; Petit, F1

Other Studies

1 other study(ies) available for ru 24926 and u-50488

ArticleYear
The dopamine D2 agonists RU 24213 and RU 24926 are also kappa-opioid receptor antagonists.
    Neuropharmacology, 1991, Volume: 30, Issue:4

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzomorphans; Dopamine Agents; Guinea Pigs; In Vitro Techniques; Male; Molecular Structure; Morphine; Narcotic Antagonists; Phenethylamines; Pyrrolidines; Rabbits; Rats; Receptors, Opioid, kappa; Receptors, Opioid, mu

1991